Nissen and Wolski [ 29 ] published a meta-analysis showing a significant increase in the risk of myocardial infarction and an increase in cardiovascular death of borderline significance in patients with diabetes receiving RGZ.
← all excerpts
Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits.
1
—
—